Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026)
Arvinas' (ARVN) quarterly Amortizatization of Intangibles came in at $1.7 million in Q1 2026, down 55.26% year-on-year from $3.8 million in Q1 2025, and down 29.17% quarter-over-quarter from $2.4 million in Q4 2025.
Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends
Arvinas' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 55.26% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 46.77% decrease from a year earlier, with the FY2025 full-year figure at $12.8 million, down 41.28% from the prior year.
- Amortizatization of Intangibles retreated to $1.7 million in Q1 2026 per ARVN's latest filing, from $2.4 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $5.9 million in Q3 2024 and bottomed at -$3.3 million in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $3.5 million (2025), against an average of $2.8 million.
- Across the five-year window, Amortizatization of Intangibles plunged 230.0% in 2022 and jumped 757.14% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $800000.0 in 2022, then soared by 525.0% to $5.0 million in 2023, then decreased by 6.0% to $4.7 million in 2024, then slumped by 48.94% to $2.4 million in 2025, then fell by 29.17% to $1.7 million in 2026.
- Per Business Quant, the three latest ARVN Amortizatization of Intangibles figures stand at $1.7 million (Q1 2026), $2.4 million (Q4 2025), and $3.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Mar 31, 2024 | 5.50 Mn |
| Mar 31, 2024 | 5.50 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Dec 31, 2023 | 5.00 Mn |